Anteris Technologies Global Corp. (AVR) vs Helus Pharma Inc. (HELP)

A side-by-side comparison of Anteris Technologies Global Corp. and Helus Pharma Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — AVR vs HELP

growth of $100 · dividends reinvested · last 1y
AVR +58.3% (+58.3%/yr)HELP +93.2% (+93.2%/yr)HELP compounded faster over this window
100150200250Start $1002026$158$193
AVR HELP

AVR vs HELP: by the numbers

  • •AVR is the larger company ($734M vs $708M market cap).
  • •HELP is profitable (329.09% net margin) while AVR runs a net loss (-4619.67%).

Metrics side by side

Valuation

MetricAVRHELP
P/S ratio327.43N/A
P/B ratio2.922.93

Profitability

MetricAVRHELP
Gross margin-16.57%100.27%
Operating margin-4908.21%317.06%
Net margin-4619.67%329.09%
ROE-41.20%-75.79%
ROIC-41.63%-73.27%

Growth (annualized)

MetricAVRHELP
Revenue CAGR (5Y)-18.92%N/A

Frequently asked

Is AVR or HELP more profitable?
HELP runs the higher net margin — AVR at -4619.67% versus HELP at 329.09%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.